210 related articles for article (PubMed ID: 22556267)
21. Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System.
Belur LR; Podetz-Pedersen KM; Sorenson BS; Hsu AH; Parker JB; Carlson CS; Saltzman DA; Ramakrishnan S; McIvor RS
Mol Cancer; 2011 Feb; 10(1):14. PubMed ID: 21310067
[TBL] [Abstract][Full Text] [Related]
22. Sex bias occurrence of hepatocellular carcinoma in Poly7 molecular subclass is associated with EGFR.
Keng VW; Sia D; Sarver AL; Tschida BR; Fan D; Alsinet C; Solé M; Lee WL; Kuka TP; Moriarity BS; Villanueva A; Dupuy AJ; Riordan JD; Bell JB; Silverstein KA; Llovet JM; Largaespada DA
Hepatology; 2013 Jan; 57(1):120-30. PubMed ID: 22899566
[TBL] [Abstract][Full Text] [Related]
23. A Transposon-Based Mouse Model of Hepatocellular Carcinoma via Hydrodynamic Tail Vein Injection.
Yu S; Vernia S
Methods Mol Biol; 2020; 2164():129-143. PubMed ID: 32607890
[TBL] [Abstract][Full Text] [Related]
24. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
25. Application of magnetic resonance imaging in transgenic and chemical mouse models of hepatocellular carcinoma.
Freimuth J; Gassler N; Moro N; Günther RW; Trautwein C; Liedtke C; Krombach GA
Mol Cancer; 2010 Apr; 9():94. PubMed ID: 20429921
[TBL] [Abstract][Full Text] [Related]
26. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
Pasquinelli C; Bhavani K; Chisari FV
Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
[TBL] [Abstract][Full Text] [Related]
27. Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background.
Chung SI; Moon H; Kim DY; Cho KJ; Ju HL; Kim DY; Ahn SH; Han KH; Ro SW
BMC Gastroenterol; 2016 Jan; 16():13. PubMed ID: 26821924
[TBL] [Abstract][Full Text] [Related]
28. A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis.
Starr TK; Scott PM; Marsh BM; Zhao L; Than BL; O'Sullivan MG; Sarver AL; Dupuy AJ; Largaespada DA; Cormier RT
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5765-70. PubMed ID: 21436051
[TBL] [Abstract][Full Text] [Related]
29. The role of bone marrow-derived cells in the origin of liver cancer revealed by single-cell sequencing.
Chen L; Yi X; Guo P; Guo H; Chen Z; Hou C; Qi L; Wang Y; Li C; Liu P; Liu Y; Xu Y; Zhang N
Cancer Biol Med; 2020 Feb; 17(1):142-153. PubMed ID: 32296582
[No Abstract] [Full Text] [Related]
30. N-nitrosodiethylamine-induced pig liver hepatocellular carcinoma model: radiological and histopathological studies.
Li X; Zhou X; Guan Y; Wang YX; Scutt D; Gong QY
Cardiovasc Intervent Radiol; 2006; 29(3):420-8. PubMed ID: 16502159
[TBL] [Abstract][Full Text] [Related]
31. Sleeping Beauty mutagenesis: exploiting forward genetic screens for cancer gene discovery.
Mann MB; Jenkins NA; Copeland NG; Mann KM
Curr Opin Genet Dev; 2014 Feb; 24():16-22. PubMed ID: 24657532
[TBL] [Abstract][Full Text] [Related]
32. An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer.
Zender L; Xue W; Zuber J; Semighini CP; Krasnitz A; Ma B; Zender P; Kubicka S; Luk JM; Schirmacher P; McCombie WR; Wigler M; Hicks J; Hannon GJ; Powers S; Lowe SW
Cell; 2008 Nov; 135(5):852-64. PubMed ID: 19012953
[TBL] [Abstract][Full Text] [Related]
33. Adaptive immunity does not strongly suppress spontaneous tumors in a Sleeping Beauty model of cancer.
Rogers LM; Olivier AK; Meyerholz DK; Dupuy AJ
J Immunol; 2013 Apr; 190(8):4393-9. PubMed ID: 23475219
[TBL] [Abstract][Full Text] [Related]
34. Transposon-mediated mutagenesis in somatic cells: identification of transposon-genomic DNA junctions.
Largaespada DA; Collier LS
Methods Mol Biol; 2008; 435():95-108. PubMed ID: 18370070
[TBL] [Abstract][Full Text] [Related]
35. Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression.
Mello T; Materozzi M; Zanieri F; Simeone I; Ceni E; Bereshchenko O; Polvani S; Tarocchi M; Marroncini G; Nerlov C; Guasti D; Bani D; Pinzani M; Galli A
Int J Cancer; 2020 Jun; 146(12):3410-3422. PubMed ID: 31721195
[TBL] [Abstract][Full Text] [Related]
36. A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice.
Dupuy AJ; Rogers LM; Kim J; Nannapaneni K; Starr TK; Liu P; Largaespada DA; Scheetz TE; Jenkins NA; Copeland NG
Cancer Res; 2009 Oct; 69(20):8150-6. PubMed ID: 19808965
[TBL] [Abstract][Full Text] [Related]
37. Of mice and men: the nonrandom genomic instability in hepatocarcinogenesis.
Calvisi DF
Hepatology; 2011 Mar; 53(3):723-5. PubMed ID: 21374655
[No Abstract] [Full Text] [Related]
38. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
39. MiR-17-92 cluster promotes hepatocarcinogenesis.
Zhu H; Han C; Wu T
Carcinogenesis; 2015 Oct; 36(10):1213-22. PubMed ID: 26233958
[TBL] [Abstract][Full Text] [Related]
40. Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors.
Wu Y; Renard CA; Apiou F; Huerre M; Tiollais P; Dutrillaux B; Buendia MA
Oncogene; 2002 Feb; 21(10):1518-26. PubMed ID: 11896580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
